10 Biotechnology Stocks Moving In Monday's Pre-Market Session

Gainers

Aimmune Therapeutics, Inc. AIMT shares increased by 15.5% to $35.87 during Monday's pre-market session. The most recent rating by Cantor Fitzgerald, on February 03, is at Overweight, with a price target of $64.00.

Cocrystal Pharma, Inc. COCP shares increased by 11.7% to $0.70.

Kadmon Holdings, Inc. KDMN stock rose 8.4% to $4.98. The most recent rating by Nomura Instinet, on January 10, is at Buy, with a price target of $10.00.

Vaxart, Inc. VXRT stock moved upwards by 7.2% to $1.34.

Intec Pharma, Inc. NTEC shares surged 6.6% to $0.31.

Vir Biotechnology, Inc. VIR stock rose 5.3% to $28.03. The most recent rating by Baird, on November 14, is at Neutral, with a price target of $17.00.

Clovis Oncology, Inc. CLVS stock rose 4.0% to $8.62. The most recent rating by B of A Securities, on January 23, is at Neutral, with a price target of $10.00.

 

Losers

Cleveland BioLabs, Inc. CBLI shares declined 19.6% to $3.40 during Monday's pre-market session.

Inovio Pharmaceuticals, Inc. INO stock plummeted 4.6% to $4.32. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.

Genprex, Inc. GNPX stock plummeted 3.3% to $1.75.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversTrading IdeasBiotechnology Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!